KalVista Pharmaceuticals, Inc.KalVista Pharmaceuticals, Inc.KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

27.200.000.00%
The 5 analysts offering 1 year price forecasts for KALV have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to KALV in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


KALV EPS for the last quarter is −0.87 USD despite the estimation of −0.92 USD. In the next quarter EPS is expected to reach −0.91 USD. Track more of KalVista Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter KalVista Pharmaceuticals, Inc. revenue is expected to reach 0.00 USD. Check out KalVista Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, KALV price target is 27.20 USD with a max estimate of 35.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile watch KalVista Pharmaceuticals, Inc. stock price chart and keep track of the current situation with KALV news and stock market news.
We've gathered opinions of 6 analysts rating KALV stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.